alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
III 

117TH CONGRESS 

1ST SESSION S. RES. 418 

Expressing support for the designation of October 3 through October 9, 

2021, as ‘‘National 4–H Week’’. 

IN THE SENATE OF THE UNITED STATES 

OCTOBER 7, 2021 

Mr. BOOZMAN (for himself, Ms. STABENOW, Ms. SMITH, Mr. MARSHALL, Mr. 

GRASSLEY, Mr. WARNOCK, Mr. CRAMER, Mr. KING, Mr. HOEVEN, Ms. 

COLLINS, Mr. BOOKER, Mr. TILLIS, Ms. ERNST, Mr. BROWN, Mr. 

BRAUN, Mrs. FISCHER, Mr. RISCH, Mr. WICKER, Mr. BLUNT, Mr. 

COONS, Mr. DURBIN, Mr. KAINE, Mr. ROUNDS, Mr. MORAN, Mr. CASSIDY, Mr. CARPER, Mrs. HYDE-SMITH, Ms. KLOBUCHAR, Mr. PETERS, 

Mr. RUBIO, Mr. HAGERTY, Mr. MANCHIN, Mr. INHOFE, Mr. LANKFORD, 

Mr. YOUNG, Mr. COTTON, Mr. BARRASSO, Mr. BENNET, Mr. LUJA ́N, Mr. 

BURR, Mr. DAINES, Mr. HEINRICH, Ms. HASSAN, Mr. CORNYN, Mrs. 

GILLIBRAND, and Mr. SCOTT of South Carolina) submitted the following 

resolution; which was referred to the Committee on Agriculture, Nutrition, and Forestry 

RESOLUTION 

Expressing support for the designation of October 3 through 

October 9, 2021, as ‘‘National 4–H Week’’. 

Whereas 4–H is the largest youth development organization 

in the United States, supporting nearly 6,000,000 young 

people across the country; 

Whereas 4–H helps young people become confident, independent, resilient, and compassionate leaders; 


pbinns on DSKJLVW7X2PROD with BILLS
2 

•SRES 418 IS 

Whereas 4–H is delivered by the Cooperative Extension System, a community of more than 100 land-grant universities across the United States that provides experiences 

for young people to learn through hands-on projects in 

the important areas of health, science, agriculture, and 

civic engagement; 

Whereas the National Institute of Food and Agriculture of 

the Department of Agriculture serves as the Federal 

partner of 4–H in collaboration with land-grant universities, the Cooperative Extension System, and the National 4–H Council; 

Whereas National 4–H Week showcases the incredible ways 

that 4–H provides opportunities for all young people and 

highlights the remarkable members of 4–H in all 50 

States and across the globe who work each day to make 

a positive impact on other individuals; 

Whereas the 4–H network of nearly 500,000 volunteers and 

3,500 professionals provides caring and supportive mentoring to all members of 4–H, helping members to grow 

into true leaders, entrepreneurs, and visionaries; and 

Whereas members of 4–H will celebrate ‘‘National 4–H 

Week’’ during the week of October 3 through October 9, 

2021: Now, therefore, be it 

1 Resolved, That the Senate— 

2 (1) supports the designation of October 3 

3 through 9, 2021, as ‘‘National 4–H Week’’; 

4 (2) recognizes the important role of 4–H in 

5 youth development and education; and 

6 (3) encourages all citizens to recognize 4–H for 

7 the significant impact the organization and members 


pbinns on DSKJLVW7X2PROD with BILLS
3 

•SRES 418 IS 

1 have made and continue to make by empowering 

2 young people with the skills needed to lead for a life3 time. 

Æ 


pbinns on DSKJLVW7X2PROD with BILLS
# L_2017285EN.01003201.xml

| 1.11.2017 | EN | Official Journal of the European Union | L 285/32 |
| --- | --- | --- | --- |

1.11.2017

EN

Official Journal of the European Union

L 285/32

---

Corrigendum to Commission Delegated Directive (EU) 2017/1975 of 7 August 2017 amending, for the purposes of adapting to scientific and technical progress, Annex III to Directive 2011/65/EU of the European Parliament and of the Council as regards an exemption for cadmium in colour converting light-emitting diodes (LEDs) for use in display systems

(
  Official Journal of the European Union L 281 of 31 October 2017
  )

On page 30, Article 2(1):

for:

‘1.   Member States shall adopt and publish, by [12 months after the date of entry into force of this directive] at the latest, the laws, regulations and administrative provisions necessary to comply with this Directive. They shall forthwith communicate to the Commission the text of those provisions.

They shall apply those provisions from [12 months after the date of entry into force of this directive + 1 day].

When Member States adopt those provisions, they shall contain a reference to this Directive or be accompanied by such a reference on the occasion of their official publication. Member States shall determine how such reference is to be made.’

read:

‘1.   Member States shall adopt and publish, by 20 November 2018 at the latest, the laws, regulations and administrative provisions necessary to comply with this Directive. They shall forthwith communicate to the Commission the text of those provisions.

They shall apply those provisions from 21 November 2018.

When Member States adopt those provisions, they shall contain a reference to this Directive or be accompanied by such a reference on the occasion of their official publication. Member States shall determine how such reference is to be made.’

On page 31, Annex, table, third column:

for:

‘Expires for all categories on [two years after the publication of the Delegated Directive in the Official Journal]’

read:

‘Expires for all categories on 31 October 2019.’

---
##### 



Exhibit 10.63
 AMERICAN REPROGRAPHICS COMPANY
2005 STOCK PLAN
 Amendment No. 1
 Adopted: May 22, 2007
  1.
    
    Section 8 of the Plan, entitled Non-Employee Directors Nonstatutory Stock Option Program,
in restated its entirety to read as follows:
 8.
    
    Non-Employee Directors Restricted Stock Award Program.
  (a) Non-Discretionary Grants.
 (b) Restricted Stock Award Provisions.
 2.
    
    Section 2(u) of the Plan is restated in its entirety to read as follows:
 (u)  Fair Market Value
 (i)
 (ii)
Arthur A. GENOVESE, III, DOC #Y09175, Appellant, v. STATE of Florida, Appellee.

Case No. 2D18-3959

District Court of Appeal of Florida, Second District.

Opinion filed April 5, 2019

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of BankFinancial Corporation (the Company) on Form 10-Q for the period ended September 30, 2008 as filed with
the Securities and Exchange Commission on the date hereof (the Report), I, F. Morgan Gasior, Chairman of the Board, Chief Executive Officer and President of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in
all material respects, the financial condition and results of operations of the Company.



|                                                             |  |                        
|------------------------------------------------------------ |  | -----------------------
|/s/ F. MORGAN GASIOR                                         |  | Dated: November 3, 2008
|F. Morgan Gasior                                             |  |                        
|Chairman of the Board, Chief Executive Officer and President |  |                        

A signed original of this written statement required by Section 906 has been provided to BankFinancial
Corporation and will be retained by BankFinancial Corporation and furnished to the Securities and Exchange Commission or its staff upon request.



45
Daniel Lanorris ALLEN, Appellant, v. STATE of Florida, Appellee.

Case No. 5D18-411

District Court of Appeal of Florida, Fifth District.

Decision filed May 7, 2019

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.
**EXHIBIT
      32.1**




The
        following certification is provided by the undersigned Chief Executive Officer
        and Chief Financial Officer of Royal Financial, Inc. on the basis of such
        officers’ knowledge and belief for the sole purpose of complying with 18 U.S.C.
        Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
        Act of 2002.
  **CERTIFICATION**
  In
        connection with the Quarterly Report of Royal Financial, Inc. (the “Company”) on
        Form 10QSB for three months ended September 30, 2006, as filed with
        the Securities and Exchange Commission on November
        14, 2006 (the “Report”), the undersigned hereby certify, pursuant to 18
        U.S.C. Section 1350, as adopted pursuant to Section 906 of the
        Sarbanes-Oxley Act of 2002, that:
  (1)  The
        Report fully complies with the requirements of Section 13(a) or 15(d) of
        the Securities Exchange Act of 1934, as amended; and
  (2)  The
        information contained in the Report fairly presents, in all material respects,
        the financial condition and results of operations of the Company.


Date: November
                    14, 2006
                  By:
                  /s/
                    Donald A. Moll
 Name: 
                    Donald A. MollTitle: 
                    President and Chief Executive Officer
 Date: November
                          14, 2006
                      By:
                      /s/
                        Leonard Szwajkowski
  Name: 
                        Leonard SzwajkowskiTitle: 
                        Senior Vice President and Chief Financial
                        Officer
 A
                    signed
                    original of this written statement required by Section 906 has been
                    provided to the Company and will be retained by the Company and
                    furnished to the
                    Securities and Exchange Commission upon request. This certification
                    accompanies
                    the Report and shall not be treated as having been filed as part
                    of this
                    Report.
Exhibit 4.2


 


	
  ST -
  1

  	
   

  	
  64,779

  



 


Fixed Rate Cumulative Perpetual
Preferred Stock, Series T, par value $0.01 per share (“Shares”)


Of


SCBT FINANCIAL CORPORATION


A Corporation organized under the
laws of the state of South Carolina


 


The United States Department of
the Treasury


 


** SIXTY FOUR THOUSAND SEVEN
HUNDRED SEVENTY-NINE (64,779) **


 


 


	
  January 16,
  2009

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  Robert
  R. Hill, Jr., President

  	
   

  	
  Renee
  R. Brooks, Secretary

  



 

















 


“THE SECURITIES
REPRESENTED BY THIS INSTRUMENT ARE NOT SAVINGS ACCOUNTS, DEPOSITS OR OTHER
OBLIGATIONS OF A BANK AND ARE NOT INSURED BY THE FEDERAL DEPOSIT INSURANCE
CORPORATION OR ANY OTHER GOVERNMENTAL AGENCY.


 


THE SECURITIES
REPRESENTED BY THIS INSTRUMENT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES
ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR THE SECURITIES LAWS OF ANY
STATE AND MAY NOT BE TRANSFERRED, SOLD OR OTHERWISE DISPOSED OF EXCEPT WHILE A
REGISTRATION STATEMENT RELATING THERETO IS IN EFFECT UNDER SUCH ACT AND
APPLICABLE STATE SECURITIES LAWS OR PURSUANT TO AN EXEMPTION FROM REGISTRATION
UNDER SUCH ACT OR SUCH LAWS. EACH PURCHASER OF THE SECURITIES REPRESENTED BY
THIS INSTRUMENT IS NOTIFIED THAT THE SELLER MAY BE RELYING ON THE EXEMPTION
FROM SECTION 5 OF THE SECURITIES ACT PROVIDED BY RULE 144A THEREUNDER.  ANY TRANSFEREE OF THE SECURITIES REPRESENTED
BY THIS INSTRUMENT BY ITS ACCEPTANCE HEREOF (1) REPRESENTS THAT IT IS A “QUALIFIED
INSTITUTIONAL BUYER” (AS DEFINED IN RULE 144A UNDER THE SECURITIES ACT), (2) AGREES
THAT IT WILL NOT OFFER, SELL OR OTHERWISE TRANSFER THE SECURITIES REPRESENTED
BY THIS INSTRUMENT EXCEPT (A) PURSUANT TO A REGISTRATION STATEMENT WHICH IS
THEN EFFECTIVE UNDER THE SECURITIES ACT, (B) FOR SO LONG AS THE SECURITIES
REPRESENTED BY THIS INSTRUMENT ARE ELIGIBLE FOR RESALE PURSUANT TO RULE 144A,
TO A PERSON IT REASONABLY BELIEVES IS A “QUALIFIED INSTITUTIONAL BUYER” AS
DEFINED IN RULE 144A UNDER THE SECURITIES ACT THAT PURCHASES FOR ITS OWN
ACCOUNT OR FOR THE ACCOUNT OF A QUALIFIED INSTITUTIONAL BUYER TO WHOM NOTICE IS
GIVEN THAT THE TRANSFER IS BEING MADE IN RELIANCE ON RULE 144A, (C) TO THE
ISSUER OR (D) PURSUANT TO ANY OTHER AVAILABLE EXEMPTION FROM THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT AND (3) AGREES THAT IT WILL GIVE TO EACH
PERSON TO WHOM THE SECURITIES REPRESENTED BY THIS INSTRUMENT ARE TRANSFERRED A
NOTICE SUBSTANTIALLY TO THE EFFECT OF THIS LEGEND.”


 


THE CORPORATION IS
AUTHORIZED TO ISSUE DIFFERENT CLASSES OF SHARES AND DIFFERENT SERIES
WITHIN A CLASS. ON REQUEST IN WRITING AND WITHOUT CHARGE, THE CORPORATION WILL
FURNISH THE SHAREHOLDER WITH A SUMMARY OF THE THE DESIGNATIONS, RELATIVE
RIGHTS, PREFERENCES, AND LIMITATIONS APPLICABLE TO EACH CLASS AND THE
VARIATIONS IN RIGHTS, PREFERENCES, AND LIMITATIONS DETERMINED FOR EACH SERIES
(AND THE AUTHORITY OF THE BOARD OF DIRECTORS TO DETERMINE VARIATIONS FOR FUTURE
SERIES).
David Jacobs BARROW v. STATE

CR-16-1021

Court of Criminal Appeals of Alabama.

December 8, 2017

Affirmed.
EX PARTE Rickey CRITTENDON

CR-17-0167

Court of Criminal Appeals of Alabama.

January 29, 2018

**DECISION WITHOUT PUBLISHED OPINION**

Mand. pet. denied.
<PAGE>


                                                                   Exhibit 10.13



 List of Contents of Exhibits and Schedules to the Royal Surplus Lines Insurance
                   Company Administrative Services Agreement



   Exhibits                              Description
   --------                              -----------

Exhibit A                          Administrative Services Intellectual
                                   Property License Agreement

Exhibit B                          RSA Reinsurance Security Guidelines

Exhibit C                          Form of Report Required Pursuant to
                                   Section 7.1



  Schedules                              Description
  ---------                              -----------

Schedule 4.5(a)                    Levels of Treaty Reinsurance
# L_2017328EN.01001901.xml

| 12.12.2017 | EN | Official Journal of the European Union | L 328/19 |
| --- | --- | --- | --- |

12.12.2017

EN

Official Journal of the European Union

L 328/19

---

COUNCIL DECISION (CFSP) 2017/2282

of 11 December 2017

amending Decision 2010/788/CFSP concerning restrictive measures against the Democratic Republic of the Congo

THE COUNCIL OF THE EUROPEAN UNION,

Having regard to the Treaty on European Union, and in particular Article 29 thereof,

Having regard to the proposal from the High Representative of the Union for Foreign Affairs and Security Policy,

Whereas:

| (1) | On 20 December 2010, the Council adopted Decision 2010/788/CFSP (1) concerning restrictive measures against the Democratic Republic of the Congo (DRC). |
| --- | --- |

(1)

On 20 December 2010, the Council adopted Decision 2010/788/CFSP (1) concerning restrictive measures against the Democratic Republic of the Congo (DRC).

| (2) | On 12 December 2016, the Council adopted Decision (CFSP) 2016/2231 (2) in response to the obstruction of the electoral process and the related human rights violations in the DRC. Decision (CFSP) 2016/2231 amended Decision 2010/788/CFSP and introduced autonomous restrictive measures under Article 3(2) thereof. |
| --- | --- |

(2)

On 12 December 2016, the Council adopted Decision (CFSP) 2016/2231 (2) in response to the obstruction of the electoral process and the related human rights violations in the DRC. Decision (CFSP) 2016/2231 amended Decision 2010/788/CFSP and introduced autonomous restrictive measures under Article 3(2) thereof.

| (3) | On the basis of a review of the measures referred to in Article 3(2) of Decision 2010/788/CFSP, the restrictive measures should be renewed until 12 December 2018. |
| --- | --- |

(3)

On the basis of a review of the measures referred to in Article 3(2) of Decision 2010/788/CFSP, the restrictive measures should be renewed until 12 December 2018.

| (4) | Decision 2010/788/CFSP should be amended accordingly, |
| --- | --- |

(4)

Decision 2010/788/CFSP should be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

In Article 9 of Decision 2010/788/CFSP, paragraph 2 is replaced by the following:

‘2.   The measures referred to in Article 3(2) shall apply until 12 December 2018. They shall be renewed, or amended as appropriate, if the Council deems that their objectives have not been met.’.

Article 2

This Decision shall enter into force on the day following that of its publication in the Official Journal of the European Union.

Done at Brussels, 11 December 2017.

For the Council

The President

F. MOGHERINI

---

(1)  Council Decision 2010/788/CFSP of 20 December 2010 concerning restrictive measures against the Democratic Republic of the Congo and repealing Common Position 2008/369/CFSP (OJ L 336, 21.12.2010, p. 30).

1

(2)  Council Decision (CFSP) 2016/2231 of 12 December 2016 amending Decision 2010/788/CFSP concerning restrictive measures against the Democratic Republic of the Congo (OJ L 336I, 12.12.2016, p. 7).

2

---
IN THE UNITED STATES DISTRICT COURT

FOR THE NORTHERN DISTRICT OF TEXAS

LUBBOCK DIVISION

CLARA J. AROCHA, )

)

 Plaintiff, )

)

v. ) CIVIL ACTION NO.

) 5:06-CV-015-C

JO ANNE B. BARNHART, ) ECF

Commissioner of Social Security, )

)

Defendant. )

ORDER

Plaintiff is appealing an adverse decision of the Defendant, Jo Anne B. Barnhart,

Commissioner of Social Security, pursuant to 42 U.S.C. § 405(g). The United States Magistrate

Judge filed her Report and Recommendation on August 23, 2006. No written objections have

been filed. It is, therefore,

ORDERED that the findings and conclusions in the Report and Recommendation are

hereby ADOPTED as the findings and conclusions of the Court and that the above-styled and

-numbered cause is hereby dismissed with prejudice.

Dated this 13th day of September, 2006.

_________________________________

SAM R. CUMMINGS

UNITED STATES DISTRICT COURT

 

 Case 5:06-cv-00015-C-BG Document 17 Filed 09/13/06 Page 1 of 1 PageID 70
Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

        Transparency

FDA Basics

                        
                FDA Fundamentals


                Respuestas a preguntas frecuentes sobre la FDA Home
          About FDA
          Transparency
          FDA BasicsTransparency FDA Basics
  	
        Share
    Post
    Linkedin

    Email
    PrintEspañol

**Provides Information About FDA and What the Agency Does**

Most Popular

What does FDA regulate?
	FDA Fundamentals
	What does FDA do?Resources For You

FDA Basics for Industry
	Follow FDA
	Contact FDA
	Respuestas a preguntas frecuentes sobre la FDA

                                                                                  Content current as of:
      03/26/2019FDA Basics                
                          

                        FDA Fundamentals


                        Respuestas a preguntas frecuentes sobre la FDA
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop
81,7('67$7(6&28572)$33($/6

)257+(1,17+&,5&8,7

)RUP5HSUHVHQWDWLRQ6WDWHPHQW

Instructions for this form: http://www.ca9.uscourts.gov/forms/form06instructions.pdf

$SSHOODQWV (List each party filing the appeal, do not use “et al.” or other abbreviations.)

1DPHVRISDUW\SDUWLHV

1DPHVRIFRXQVHOLIDQ\

$GGUHVV

7HOHSKRQHQXPEHUV

(PDLOV

,VFRXQVHOUHJLVWHUHGIRU(OHFWURQLF)LOLQJLQWKHWK&LUFXLW" <HV 1R

$SSHOOHHV (List only the names of parties and counsel who will oppose you on appeal. List 

separately represented parties separately.) 

1DPHVRISDUW\SDUWLHV

1DPHVRIFRXQVHOLIDQ\

$GGUHVV

7HOHSKRQHQXPEHUV

(PDLOV

To list additional parties and/or counsel, use next page.

Feedback or questions about this form? Email us at forms@ca9.uscourts.gov

)RUP 1 New 12/01/2018

4XDOFRPP,QFRUSRUDWHG

*DU\$%RUQVWHLQ

<RQDWDQ(YHQ

&5$9$7+6:$,1(	0225(//3

(LJKWK$YHQXH1HZ<RUN1<



JERUQVWHLQ#FUDYDWKFRP\HYHQ#FUDYDWKFRP

)HGHUDO7UDGH&RPPLVVLRQ

-HQQLIHU0LOLFL

WK6WUHHW6::DVKLQJWRQ'&



MPLOLFL#IWFJRY

Case 5:17-cv-00220-LHK Document 1499-1 Filed 05/31/19 Page 1 of 3
&RQWLQXHGOLVWRISDUWLHVDQGFRXQVHO(attach additional pages as necessary)

Feedback or questions about this form? Email us at forms@ca9.uscourts.gov

$SSHOODQWV

1DPHVRISDUW\SDUWLHV

1DPHVRIFRXQVHOLIDQ\

$GGUHVV

7HOHSKRQHQXPEHUV

(PDLOV

,VFRXQVHOUHJLVWHUHGIRU(OHFWURQLF)LOLQJLQWKHWK&LUFXLW" <HV 1R

$SSHOOHHV

1DPHVRISDUW\SDUWLHV

1DPHVRIFRXQVHOLIDQ\

$GGUHVV

7HOHSKRQHQXPEHUV

(PDLOV

1DPHVRISDUW\SDUWLHV

1DPHVRIFRXQVHOLIDQ\

$GGUHVV

7HOHSKRQHQXPEHUV

(PDLOV

)RUP 2 New 12/01/2018

4XDOFRPP,QFRUSRUDWHG

5REHUW9DQ1HVW(XJHQH03DLJH&RG\6+DUULV-XVWLQD6HVVLRQV

.(.(59$11(67	3(7(56//3

%DWWHU\6WUHHW



rvannest@keker.com / epaige@keker.com / charris@keker.com / jsessions@keker.com

Case 5:17-cv-00220-LHK Document 1499-1 Filed 05/31/19 Page 2 of 3
&RQWLQXHGOLVWRISDUWLHVDQGFRXQVHO(attach additional pages as necessary)

Feedback or questions about this form? Email us at forms@ca9.uscourts.gov

$SSHOODQWV

1DPHVRISDUW\SDUWLHV

1DPHVRIFRXQVHOLIDQ\

$GGUHVV

7HOHSKRQHQXPEHUV

(PDLOV

,VFRXQVHOUHJLVWHUHGIRU(OHFWURQLF)LOLQJLQWKHWK&LUFXLW" <HV 1R

$SSHOOHHV

1DPHVRISDUW\SDUWLHV

1DPHVRIFRXQVHOLIDQ\

$GGUHVV

7HOHSKRQHQXPEHUV

(PDLOV

1DPHVRISDUW\SDUWLHV

1DPHVRIFRXQVHOLIDQ\

$GGUHVV

7HOHSKRQHQXPEHUV

(PDLOV

)RUP 2 New 12/01/2018

4XDOFRPP,QFRUSRUDWHG

5LFKDUG67DIIHW:LOODUG.7RP*HRIIUH\7+ROW]

025*$1/(:,6	%2&.,86//3

2QH0DUNHW3OD]D6SHDU6WUHHW7RZHU6DQ)UDQFLVFR&$



richard.taffet@morganlewis.com / willard.tom@morganlewis.com / gholtz@morganlewis.com

Case 5:17-cv-00220-LHK Document 1499-1 Filed 05/31/19 Page 3 of 3